Harry Miao Email & Phone Number
VP, Clinical Development @ Kite Pharma
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Harry Miao Location
- United States
Harry Miao Work
- 2021 -now VP, Clinical Development @
- 2018 -2021 Executive Medical Director @
- 2016 -2018 Executive Director @ Epizyme
- 2014 -2016 Executive Director @
- 2010 -2014 Director @
- 2007 -2010 Director, Clinical Development @
- 2000 -2007 Associate Director @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Harry Miao Education
- Harvard University
- Hebrew University of Jerusalem
- Qingdao University
Harry Miao Skills
- Oncology Clinical Research
- Translational Medicine
- Drug Development
- Drug Discovery
- Biotechnology
- Biopharmaceuticals
- Biomarkers
- Pharmaceutical Industry
- Clinical Pharmacology
- Molecular & Cellular Biology
- Antibodies
- CRO
- IND
- Oncology
- Small Molecules
- GCP
- Immunology
- FDA
- Clinical Research
- Regulatory Submissions
- Biochemistry
- Molecular Biology
- U.S. Food and Drug Administration (FDA)
- Cell Biology
- CRO Management
- Technology Transfer
- Cell
- Clinical Development
- Customer Service
- Molecular and Cellular Biology
- Development
- CEP
- Healthcare
- Microsoft Excel
- u.s. Food and Drug Administration Fda
- u.s. Food and Drug Administration
Harry Miao Summary
- Harry Miao, based in United States, is currently a VP, Clinical Development at Kite Pharma. Harry Miao brings experience from previous roles at Takeda Oncology, Epizyme, Incyte and Sanofi. Harry Miao holds a Harvard University. With a robust skill set that includes Oncology Clinical Research, Translational Medicine, Drug Development, Drug Discovery, Biotechnology and more. Harry Miao has 1 emails on RocketReach.
Looking for a different Harry Miao?
Find contact details for 700 million professionals.
Top Kite Pharma Employees
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co